11 Einträge gefunden

1. Allogeneic stem-cell transplantation in patients with refractory acute leukemia: a long-term follow-up.

   1. Oyekunle, A A
   2. Kröger, Nicolaus
   3. Zabelina, Tatjana
   4. Ayuketang Ayuk, Francis
   5. Schieder, H
   6. Renges, H
   7. Fehse, N

   2006 - Forschungsinformationssystem des UKE
2. CD34(+)-selected stem cell boost for delayed or insufficient engraftment after allogeneic stem cell transplantation.

   1. Oyekunle, Aa
   2. Koehl, U
   3. Schieder, H
   4. Ayuketang Ayuk, Francis
   5. Renges, H
   6. Fehse, N
   7. Zabelina, Tatjana

   2006 - Forschungsinformationssystem des UKE
3. Reduced-toxicity conditioning with treosulfan, fludarabine and ATG as preparative regimen for allogeneic stem cell transplantation (alloSCT) in elderly patients with secondary acute myeloid leukemia (sAML) or myelodysplastic syndrome (MDS).

   1. Kröger, Nicolaus
   2. Shimoni, A
   3. Zabelina, Tatjana
   4. Schieder, H
   5. Panse, Jens
   6. Ayuketang Ayuk, Francis
   7. Wolschke, Christine

   2006 - Forschungsinformationssystem des UKE
4. Long-term follow-up of allogeneic stem cell transplantation in patients with severe aplastic anemia after conditioning with cyclophosphamide plus antithymocyte globulin.

   1. Kröger, N
   2. Zabelina, Tatjana
   3. Renges, H
   4. Krüger, W
   5. Kordes, Uwe
   6. Rischewski, J
   7. Schrum, Johanna

   2002 - Forschungsinformationssystem des UKE
5. In vivo T cell depletion with pretransplant anti-thymocyte globulin reduces graft-versus-host disease without increasing relapse in good risk myeloid leukemia patients after stem cell transplantation from matched related donors.

   1. Kröger, N
   2. Zabelina, Tatjana
   3. Krüger, W
   4. Renges, H
   5. Stute, N
   6. Rischewski, J
   7. Sonnenberg, S

   2002 - Forschungsinformationssystem des UKE
6. Patient cytomegalovirus seropositivity with or without reactivation is the most important prognostic factor for survival and treatment-related mortality in stem cell transplantation from unrelated donors using pretransplant in vivo T-cell depletion with anti-thymocyte globulin.

   1. Kröger, N
   2. Zabelina, Tatjana
   3. Krüger, W
   4. Renges, H
   5. Stute, N
   6. Schrum, Johanna
   7. Kabisch, H

   2001 - Forschungsinformationssystem des UKE
7. Real-time quantitative Y chromosome-specific PCR (QYCS-PCR) for monitoring hematopoietic chimerism after sex-mismatched allogeneic stem cell transplantation.

   1. Fehse, B
   2. Chukhlovin, A
   3. Kühlcke, K
   4. Marinetz, O
   5. Vorwig, O
   6. Renges, H
   7. Krüger, W

   2001 - Forschungsinformationssystem des UKE
8. Comparison of total body irradiation vs busulfan in combination with cyclophosphamide as conditioning for unrelated stem cell transplantation in CML patients.

   1. Kröger, N
   2. Zabelina, Tatjana
   3. Krüger, W
   4. Renges, H
   5. Stute, N
   6. Kabisch, H
   7. Jaburg, N

   2001 - Forschungsinformationssystem des UKE
9. A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome.

   1. Kröger, N
   2. Schetelig, J
   3. Zabelina, Tatjana
   4. Krüger, W
   5. Renges, H
   6. Stute, N
   7. Schrum, Johanna

   2001 - Forschungsinformationssystem des UKE
10. Donor lymphocyte infusion enhances remission status in patients with persistent disease after allografting for multiple myeloma.

    1. Kröger, N
    2. Krüger, W
    3. Renges, H
    4. Zabelina, Tatjana
    5. Stute, N
    6. Jung, Roman
    7. Wittkowsky, G

    2001 - Forschungsinformationssystem des UKE
11. Anti-thymocyte-globulin as part of the preparative regimen prevents graft failure and severe graft versus host disease (GvHD) in allogeneic stem cell transplantation from unrelated donors.

    1. Kröger, N
    2. Zabelina, Tatjana
    3. Krüger, W
    4. Renges, H
    5. Stute, N
    6. Dürken, M
    7. Graf von Finkenstein, F

    2001 - Forschungsinformationssystem des UKE